Swedish Paper and Forestry Products Stock News

OM:BIOG B
OM:BIOG BBiotechs

How Investors Are Reacting To BioGaia (OM:BIOG B) Beating Q4 Profit And Margin Expectations

BioGaia recently reported preliminary fourth-quarter figures indicating that both sales and operating profit exceeded market expectations, with margins also coming in higher than anticipated. This early confirmation of strong profitability further underlines BioGaia’s positioning in the global probiotics market ahead of its detailed Q4 2025 report on 12 February 2026. Next, we’ll examine how this stronger-than-expected profitability update may influence BioGaia’s investment narrative and...
OM:WIHL
OM:WIHLReal Estate

Did Full Leasing of Bricks and New Government Tenant Just Shift Wihlborgs Fastigheter's (OM:WIHL) Investment Narrative?

Wihlborgs Fastigheter AB (publ) has renewed a six-year lease for 12,000 sqm at the Bricks property in Ideon and signed a separate six-year, 1,000 sqm lease with a government agency, resulting in the building becoming fully leased from May 2026 onward. This shift from historically high vacancy to full occupancy at Bricks underlines how improved services, diversified premises, and sustainability-focused upgrades have turned the Mobilvägen cluster into an attractive hub for around 50 tenants...
OM:LEVEL
OM:LEVELElectronic

European Market Insights: Nordic LEVEL Group AB (publ.) And 2 Other Promising Penny Stocks

As the European market navigates a modest recovery, with the STOXX Europe 600 Index seeing gains amid earnings optimism, investors are keenly observing opportunities that might arise from smaller or newer companies. Penny stocks, though an older term, continue to capture interest by offering potential growth at lower price points. When these stocks are supported by strong financial health and fundamentals, they can present compelling opportunities for those looking to explore underappreciated...
OM:INWI
OM:INWIBuilding

Does Inwido's (OM:INWI) SEK 5.50 Dividend Clarify Its Long-Term Capital Allocation Priorities?

Inwido AB (publ) has confirmed an annual dividend of SEK 5.50 per share, with an ex-date of May 28, 2026, a record date of May 29, 2026, and payment scheduled for June 3, 2026. The dividend affirmation, together with the scheduled Q4 2025 earnings call on February 3, 2026, highlights Inwido’s focus on shareholder returns and transparency. We will now examine how the confirmed SEK 5.50 annual dividend shapes Inwido’s investment narrative and future income appeal. Find companies with promising...
OM:LOOMIS
OM:LOOMISCommercial Services

Top European Dividend Stocks To Watch In February 2026

As the eurozone economy continues its modest recovery with strengthened confidence and investment, European markets have shown resilience despite mixed performances among major stock indexes. In this environment, dividend stocks can offer investors a potential source of steady income and stability, making them an attractive option to consider as part of a diversified portfolio.
OM:ANOD B
OM:ANOD BIT

Addnode Group (OM:ANOD B) Margin Improvement Reinforces Bullish Profitability Narratives

Addnode Group (OM:ANOD B) has wrapped up FY 2025 with fourth quarter revenue of SEK 1,564 million and basic EPS of 1.01 SEK, alongside trailing twelve month revenue of SEK 5,793 million and EPS of 2.87 SEK that frame the latest print in a wider context. The company has seen quarterly revenue move between SEK 1,311 million and SEK 1,564 million over the year, while quarterly EPS ranged from 0.40 SEK to 1.01 SEK. This gives investors a clear read on how the top and bottom line have tracked...
OM:SKF B
OM:SKF BMachinery

Do SKF’s Softer Q4 Earnings and SEK 7.75 Dividend Reveal a Strategic Shift for (OM:SKF B)?

AB SKF (publ) recently reported fourth-quarter 2025 results showing sales of SEK 21,969 million and net income of SEK 568 million, while also guiding for a currency impact of around SEK 800 million on first-quarter 2026 operating profit based on exchange rates as of December 31, 2025. At the same time, the company’s Board proposed a dividend of SEK 7.75 per share in two instalments and announced that Board member Susanna Schneeberger will not stand for re-election at the 2026 Annual General...
OM:BOL
OM:BOLMetals and Mining

Boliden (OM:BOL) EPS Surge Tests Bearish Narrative On Earnings Durability

Boliden (OM:BOL) has just wrapped up FY 2025 with fourth quarter revenue of SEK28.1b and basic EPS of SEK15.31, while trailing twelve month revenue sits at SEK93.5b with EPS of SEK33.39, setting a clear earnings-season marker for investors. Over the last few reporting periods the company has seen revenue move from SEK25.8b in Q4 2024 to SEK28.1b in Q4 2025 and basic EPS shift from SEK10.95 to SEK15.31, with trailing net profit margin easing from 11.2% to 10.1%. The latest numbers put the...
OM:HM B
OM:HM BSpecialty Retail

A Look At H & M Hennes & Mauritz (OM:HM B) Valuation After Earnings Dividend Hike And Completed Buyback

Why this cluster of news matters for H & M Hennes & Mauritz (OM:HM B) H & M Hennes & Mauritz (OM:HM B) just wrapped up a busy update, combining full year 2025 results, fresh sales guidance, a higher proposed dividend, and confirmation that its latest share buyback programme is complete. For the year to 30 November 2025, the company reported sales of SEK 228,285 million compared with SEK 234,478 million in the previous year, while net income was SEK 12,158 million compared with SEK 11,621...
OM:PNDX B
OM:PNDX BReal Estate

Did Pandox’s (OM:PNDX B) Crowne Plaza Antwerp Sale Quietly Redefine Its Leasing-Led Strategy?

Pandox has completed the sale of the Crowne Plaza Antwerp hotel in Belgium, including property and operations, for approximately €19 million, removing a 262-room asset that generated about €11 million in 2024 revenue from its portfolio. This exit from an Own Operations asset underscores Pandox’s ongoing effort to reshape its portfolio and place greater emphasis on core holdings and leasing-oriented income. We’ll now explore how this hotel divestment, and the shift toward a more...
OM:EQL
OM:EQLHealthcare

Margin Compression At EQL Pharma (OM:EQL) Challenges Defensive Generics Narrative

Latest Quarter Sets the Stage for EQL Pharma’s Next Chapter EQL Pharma (OM:EQL) just posted Q3 2026 revenue of 118.9 million SEK with basic EPS of 0.33 SEK, alongside trailing twelve month EPS of 1.00 SEK on 425.8 million SEK of revenue. These figures put fresh numbers behind the recent share price of 61.5 SEK. The company has seen quarterly revenue move from 92.2 million SEK in Q3 2025 to 118.9 million SEK in Q3 2026, while basic EPS shifted from 0.35 SEK to 0.33 SEK over the same periods...